Chargement en cours...
Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants
BACKGROUND: Patent ductus arteriosus (PDA) complicates the clinical course of preterm infants and increases the risk of adverse outcomes. Indomethacin has been the standard treatment to close a PDA but is associated with renal, gastrointestinal, and cerebral side effects. Ibuprofen has less effect o...
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2019
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587108/ https://ncbi.nlm.nih.gov/pubmed/31222841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004213.pub4 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|